Neuromics' FBS and National Cancer Institutes

 Best Price and Performance 

I was honored to work with Jessey at National Cancer Institute (NCI).

The were determining whether to change partners. According to Jessey, there were 24 lab PIs who would be supplied with the winner's FBS Although we proved competitive, we were not selected.

The study was conducted with only premium grade FBS (most expensive). We are announcing a new Preferred FBS this Monday 10/25. It works well for supplementing define media and works great for most human primary sells. And works fabulous for human and animal cancer cells.

Interested in learning more? Contact me at pshuster@neuromics.com or 612-801-1007. Pete Shuster CEO, Neuromics.

Neuromics-3D Human Blood Brain Barrier!

Compound Penetration Study

  

Classification: Low permeability: Pe < 1.00 nm/s 

Moderate permeability: 1.00 < Pe < 10.0 nm/s 

High permeability: Pe > 10.0 nm/s 

* The signal responses of Atenolol , 

Sulpiride, and Cimetidine in receiver samples were undetectable.

For the convenience of calculation, 

1/300 of the measured peak area ratio (PAR) of the relevant AD (A>B Donor) 

samples were used as the PAR values of Atenolol , Sulpiride, and Cimetidine 

in receiver samples.

Check out the study-

https://www.neuromics.com/ittrium/reference/D8xf65cx8x1/BBB%20Penetration%20Data.pdf